Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

17.75
Delayed Data
As of Jul 25
 -0.37 / -2.04%
Today’s Change
11.60
Today|||52-Week Range
37.04
-7.98%
Year-to-Date

Today’s Trading

Previous close18.12
Today’s open18.24
Day’s range17.68 - 18.37
Volume527,166
Average volume (3 months)484,438
Market cap$664.6M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-102.67%
Earnings growth (next 5 years)+138.00%
Revenue growth (last year)+254.19%
P/E ratio7.9
Price/Sales7.26
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...+0.10+0.54%
INOInovio Pharmaceutica...+0.02+0.22%
ANIPANI Pharmaceuticals ...-0.03-0.05%
ATRAAtara Biotherapeutic...+0.41+1.83%
Data as of 07/25/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs